Cognidox Announces CEO Transition as Company Enters Next Phase of Growth

Cambridge, UK – [12 February 2026] – Cognidox, a leading provider of electronic Quality Management System software for life sciences, medical device and high-tech product developers, today announced a planned leadership transition. Joe Byrne is stepping down as Chief Executive Officer, with Alexander Thomson appointed as his successor.

The transition follows Cognidox’s acquisition by Recur Software in 2025, a milestone that marked the beginning of a new phase of investment and growth for the business.

Recognising Joe Byrne’s Leadership

Joe Byrne has served as CEO of Cognidox during a period of significant progress, launching the company into the medical device and life sciences industries and strengthening its position as a trusted partner to semiconductor development teams. Under his leadership, Cognidox continued to expand its customer base, deepen its focus on regulated markets, and successfully complete its acquisition by Recur Software.

Commenting on the transition, Joe Byrne said:

“It has been a privilege to lead Cognidox and work alongside such a talented team. Together, we’ve built a company that customers trust with their most critical processes and documents. With Cognidox now part of Recur, the business is exceptionally well positioned for its next stage of growth, and I’m confident Alexander is the right person to lead that journey.”

Joe will continue to support a smooth handover and wishes the team continued success.

Welcoming Alexander Thomson as CEO

Alexander Thomson brings extensive leadership experience and a strong track record of scaling B2B software businesses. As CEO, he will focus on building on Cognidox’s strengths in quality management, document control, and compliance, while accelerating innovation and long-term growth.

Alexander Thomson commented:

“Cognidox has earned an outstanding reputation in the life sciences and high-tech product industries. I’m excited to join the team at this pivotal moment and to work closely with our customers, partners, and Recur to continue investing in the platform, including new capabilities that help customers work more efficiently, securely, and at scale.”

Continued Focus and Customer Assurance

Cognidox customers can expect uninterrupted service, support, and product direction. The existing leadership team and product roadmap remain firmly in place, with ongoing investments supported by Recur Software’s long-term commitment to the business.

The company will continue to focus on helping customers manage complex product development and quality processes with confidence, particularly in medical device and high-tech engineering environments where compliance, traceability, and control are critical.

About Cognidox

Cognidox is a lean, browser-based eQMS for life sciences, medical devices, and high-tech product developers. Its platform helps companies achieve compliance with ISO 13485, FDA 21 CFR Part 11, EU Annexe 11, and many other standards, while improving collaboration and efficiency.

www.cognidox.com